查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2104537

神經生物標記免疫檢測市場：依產品類型、疾病、最終用戶、國家及地區分類－產業分析、市場規模、市場佔有率及2026年至2033年預測

Immunoassay for Neurological Biomarkers Market, By Product Type, By Disease, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 368 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年，神經系統疾病生物標記免疫檢測的市場規模將達到 10.903 億美元，並有望從 2026 年到 2033 年以 9.1% 的複合年成長率成長。

神經系統疾病生物標記的免疫檢測是一種先進的分析檢測方法，它利用高度特異性的抗原-抗體相互作用來識別和定量與神經系統疾病相關的生物標記。這些檢測法在各種神經系統疾病的診斷、疾病進展監測、預後判斷和療效評估中發揮至關重要的作用，使臨床醫生和研究人員能夠深入了解這些疾病。

神經系統生物標記免疫檢測測定市場—市場動態

神經系統疾病的日益普遍和生物標記檢測技術的進步預計將推動市場需求。

由於全球神經退化性疾病疾病和神經系統疾病的盛行率不斷上升，用於神經系統生物標記的免疫檢測市場正經歷顯著成長。阿茲海默症、多發性硬化症、帕金森氏症、肌萎縮側索硬化症（ALS）以及各種失智症疾病的盛行率不斷增加，是推動該市場成長的主要因素。免疫檢測對於在出現主要臨床症狀之前早期檢測疾病相關生物標記至關重要。檢測靈敏度的不斷提高、多重檢測能力的增強以及血液來源生物標記檢測能力的提升，也是推動市場成長的因素。此外，微創檢測技術的日益普及也促進了市場需求。

推動市場成長的另一個關鍵因素是免疫檢測技術的持續發展以及精準醫療在神經系統疾病治療中日益普及。對神經科學研究、生物標記發現和檢驗專案以及伴隨診斷開發投入的增加，正在推動整個產業的創新。主要市場趨勢包括阿茲海默症血液檢測的商業化以及能夠從單一檢體中分析多種生物標記的多重免疫檢測平台的出現。這些創新提高了診斷準確性，簡化了臨床決策，降低了檢測的複雜性，並促進了神經系統生物標記檢測在醫療機構和診斷檢查室的更廣泛應用。此外，對神經科學和生物標記檢測研究投入的增加也推動了市場成長。因此，先進免疫檢測在神經系統疾病病理生理分層的重要性日益凸顯。

神經系統生物標記免疫檢測市場－市場細分分析：

全球神經生物標記免疫檢測市場按產品類型、疾病、最終用戶和地區進行細分。

疾病可分為四類：阿茲海默症、帕金森氏症、多發性硬化症和其他疾病。阿茲海默症在全球發病率較高，因此在神經系統疾病生物標記的免疫檢測市場中佔據相當大的佔有率。此外，醫療保健支出的成長和免疫檢測技術的進步正在加速阿茲海默症領域的需求。

神經系統生物標記免疫檢測市場—區域分析

亞太地區是神經生物標記免疫檢測分析市場成長最快的地區之一。這一成長主要得益於醫療保健支出的增加、神經系統疾病盛行率的上升以及對診斷和研究基礎設施的持續投入。中國、日本、韓國和印度都在積極發展神經科學研究項目，致力於提升臨床診斷能力，並推廣尖端生物標記檢測技術。人口快速老化、人們對神經退化性疾病的認知不斷提高，以及該地區對早期診斷和預防醫學的日益重視，也推動了市場成長。北美地區憑藉其強大的醫療保健基礎設施、對神經科學研究的大量投入以及對先進診斷解決方案的早期應用，繼續保持主要市場的地位。領先的生物技術和診斷公司、政府和私營部門的大力支持，以及基於生物標記的檢測在阿茲海默症和帕金森氏症等疾病中的應用日益廣泛，都持續推動全部區域的市場擴張。

目錄

第1章：神經生物標記免疫檢測市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：神經生物標記免疫檢測的關鍵市場趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：神經生物標記免疫檢測方法的產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章：神經生物標記免疫檢測市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：神經生物標記免疫檢測的市場趨勢

  • 2025 年神經系統生物標記免疫檢測方法市佔率分析。
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章：神經生物標記免疫檢測市場：依產品類型分類

  • 概述
    • 基於細分市場的市場佔有率分析：按產品類型
    • 裝置
    • 試劑
    • 服務

第8章：神經系統生物標記的免疫檢測市場：依疾病分類

  • 概述
    • 基於細分市場的市佔率分析：依疾病分類
    • 阿茲海默症
    • 帕金森氏症
    • 多發性硬化症
    • 創傷性腦損傷（TBI）
    • 其他

第9章：神經生物標記免疫檢測市場：依最終用戶分類

  • 概述
    • 基於細分市場的市場佔有率分析：按最終用戶分類
    • 醫院
    • 診斷檢查室
    • 研究機構
    • 其他

第10章：神經生物標記免疫檢測市場：按地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 丹麥
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 台灣
    • 越南
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 伊朗
    • 卡達
    • 其他中東和非洲國家

第11章 主要供應商分析：神經生物標記的免疫檢測產業

  • 競爭基準
    • 競爭對手儀錶板
    • 競爭定位
  • 公司簡介
    • Roche Diagnostics
    • Siemens Healthineers
    • Fujirebio
    • Quanterix Corporation
    • Revvity, Inc.
    • Abbott Laboratories
    • Bio-Rad Laboratories, Inc.
    • Thermo Fisher Scientific Inc.
    • Sysmex Corporation
    • Becton, Dickinson and Company（BD）
    • Agilent Technologies, Inc.
    • Bio-Techne Corporation
    • QIAGEN
    • Diasorin SpA
    • Beckman Coulter, Inc.（Danaher）
    • Others

第12章：AnalystView 的全景視圖

簡介目錄
Product Code: ANV7022

Immunoassay for Neurological Biomarkers Market size was valued at USD 1,090.3 Million in 2025, expanding to a CAGR of 9.1% from 2026 to 2033.

Immunoassays for neurological biomarkers are advanced analytical testing methods that leverage highly specific antigen-antibody interactions to identify and quantify biomarkers linked to neurological disorders. These assays play a critical role in the diagnosis, disease monitoring, prognosis, and therapeutic assessment of various neurological conditions, enabling clinicians and researchers to gain valuable insights on diseases.

Immunoassay for Neurological Biomarkers Market- Market Dynamics

Growing prevalence of neurological disorders and advancement in biomarker testing are expected to propel market demand

The global immunoassay for neurological biomarkers market is experiencing significant growth owing to the rising prevalence of neurodegenerative and neurological disorders worldwide. The market is driven by the increase in prevalence of diseases like Alzheimer's disease, sclerosis, Parkinson's disease, amyotrophic lateral sclerosis (ALS) and various types of dementia. Immunoassays are often essential in the early detection of disease-associated biomarkers, often preceding the development of major clinical symptoms. Continued improvements in assay sensitivity, the ability to perform multiplex testing and detection of blood-based biomarkers are also driving market growth. Market demand is also driven by the growing availability of minimally invasive testing.

Another important factor driving the market growth is the continuous development of immunoassay technologies and the increasing acceptance of precision medicine in the neurological care. Growing investments in neuroscience studies, biomarker discovery and validation programs and companion diagnostic development are encouraging innovation across the industry. Key market trends include increasing commercialization of blood-based diagnostic tests for Alzheimer's disease, multiple immunoassay platforms to analyze multiple biomarkers from a single sample. These innovations are improving diagnostic accuracy, simplifying clinical decision making, reducing testing complexity and enabling broader implementation of neurological biomarker testing in healthcare facilities, diagnostic laboratories etc. Furthermore, rising investments in the research of neuroscience, biomarker tests are also augmenting the market growth. Thus, sophisticated immunoassays are increasingly important for disease stratification in neurological disorders.

Immunoassay for Neurological Biomarkers Market- Segmentation Analysis:

The Global Immunoassay for Neurological Biomarkers Market is segmented on the basis of Product Type, Disease, End User, and Region.

The market is divided into four categories based on Disease: Alzheimer's disease, Parkinson's disease, multiple sclerosis, and others. Alzheimer's disease accounts for the substantial share of the immunoassay for neurological biomarkers market owing to its high prevalence across the globe. Further, increasing healthcare spending and developments immunoassay technologies is accelerating Alzheimer disease segment demand.

Immunoassay for Neurological Biomarkers Market- Geographical Insights

The Asia-Pacific region is one of the fastest growing markets for immunoassays in neurological biomarker testing. The growth is driven by increasing healthcare spending, rising prevalence of neurological diseases, and continued investment in diagnostic and research infrastructure. China, Japan, South Korea and India are all actively developing their neuroscience study programs, improving clinical diagnostic capabilities and access to cutting-edge biomarker testing technologies. The market growth is also driven by the region's rapidly aging population, rising awareness about neurodegenerative diseases, and increasing focus on early diagnosis and preventive healthcare. North America continues to be a leading market, supported by a strong healthcare infrastructure, significant investment in neurological research, and early adoption of advanced diagnostic solutions. The presence of leading biotechnology and diagnostics companies, strong government and private-sector funding, and growing utilization of biomarker-based testing for conditions such as Alzheimer's disease and Parkinson's disease continue to support market expansion across the region.

U.S. Immunoassay for Neurological Biomarkers Market- Key Insights

The United States is an important market for immunoassays for neurological biomarkers testing, due to the country's strong biotechnology industry, a well-developed neuroscience study environment and early adoption of innovative diagnostic solutions. The increasing prevalence of Alzheimer's disease, Parkinson's disease, multiple sclerosis, and other neurodegenerative diseases is driving the demand for highly accurate and minimally invasive biomarker-based diagnostic solutions. Healthcare organizations and clinicians are increasingly using biomarker testing to help detect disease earlier and improve diagnosis.

Immunoassay for Neurological Biomarkers Market- Competitive Landscape:

The immunoassay for neurological biomarkers market is characterized by intense competition, with major diagnostics manufacturers, life sciences companies, and biotechnology firms focusing on enhancing assay accuracy. Industry participants are making significant investments in research and development to identify novel neurological biomarkers, improve analytical performance, etc. In addition, strategic partnerships and collaborations with pharmaceutical companies, research institutes is fueling market growth. These strategic initiatives are helping market players strengthen their competitive positions while expanding the clinical utility of neurological biomarker testing.

Recent Developments:

In January 2025, Roche expanded its neurological diagnostics portfolio by introducing advanced blood-based biomarker testing solutions aimed at improving the early identification, diagnosis, etc.

In June 2025, Abbott Laboratories boosted its immunodiagnostics portfolio through enhancements to automated neurological biomarker testing capabilities, aiding improved laboratory efficiency, and advanced diagnostic solutions.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET KEY PLAYERS

  • Roche Diagnostics
  • Siemens Healthineers
  • Fujirebio
  • Quanterix Corporation
  • Revvity, Inc.
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific Inc.
  • Sysmex Corporation
  • Becton, Dickinson and Company (BD)
  • Agilent Technologies, Inc.
  • Bio-Techne Corporation
  • QIAGEN
  • Diasorin S.p.A.
  • Beckman Coulter, Inc. (Danaher)
  • Others

GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020-2033

  • Instruments
  • Reagents
  • Services

GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY DISEASE- MARKET ANALYSIS, 2020-2033

  • Alzheimer's Disease
  • Parkinson's Disease
  • Multiple Sclerosis
  • Traumatic Brain Injury (TBI)
  • Others

GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY END USER- MARKET ANALYSIS, 2020-2033

  • Hospitals
  • Diagnostic Laboratories
  • Research Institutes
  • Others

GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY REGION- MARKET ANALYSIS, 2020-2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Immunoassay for Neurological Biomarkers Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
  • 2.2. Competitive Insights

3. Immunoassay for Neurological Biomarkers Key Market Trends

  • 3.1. Immunoassay for Neurological Biomarkers Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Immunoassay for Neurological Biomarkers Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Immunoassay for Neurological Biomarkers Market Opportunities
  • 3.4. Immunoassay for Neurological Biomarkers Market Future Trends

4. Immunoassay for Neurological Biomarkers Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Immunoassay for Neurological Biomarkers Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Immunoassay for Neurological Biomarkers Market Landscape

  • 6.1. Immunoassay for Neurological Biomarkers Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Immunoassay for Neurological Biomarkers Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2025 & 2033 (%)
    • 7.1.2. Instruments
    • 7.1.3. Reagents
    • 7.1.4. Services

8. Immunoassay for Neurological Biomarkers Market - By Disease

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Disease, 2025 & 2033 (%)
    • 8.1.2. Alzheimer's Disease
    • 8.1.3. Parkinson's Disease
    • 8.1.4. Multiple Sclerosis
    • 8.1.5. Traumatic Brain Injury (TBI)
    • 8.1.6. Others

9. Immunoassay for Neurological Biomarkers Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Diagnostic Laboratories
    • 9.1.4. Research Institutes
    • 9.1.5. Others

10. Immunoassay for Neurological Biomarkers Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Immunoassay for Neurological Biomarkers Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Immunoassay for Neurological Biomarkers Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.16. Denmark
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.16.3. Denmark Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.16.4. Denmark Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
      • 10.3.16.5. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.17. Rest of Europe
      • 10.3.17.1. Overview
      • 10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.17.4. Rest of the Europe Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
      • 10.3.17.5. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Immunoassay for Neurological Biomarkers Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.15. Taiwan
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.15.3. Taiwan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.15.4. Taiwan Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
      • 10.4.15.5. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.16. Vietnam
      • 10.4.16.1. Overview
      • 10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.16.3. Vietnam Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.16.4. Vietnam Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
      • 10.4.16.5. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.17. Rest of APAC
      • 10.4.17.1. Overview
      • 10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.17.4. Rest of APAC Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
      • 10.4.17.5. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Immunoassay for Neurological Biomarkers Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Immunoassay for Neurological Biomarkers Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.13. Iran
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.13.3. Iran Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.13.4. Iran Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
      • 10.6.13.5. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.14. Qatar
      • 10.6.14.1. Overview
      • 10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.14.3. Qatar Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.14.4. Qatar Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
      • 10.6.14.5. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.15. Rest of MEA
      • 10.6.15.1. Overview
      • 10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.15.4. Rest of MEA Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
      • 10.6.15.5. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

11. Key Vendor Analysis- Immunoassay for Neurological Biomarkers Industry

  • 11.1. Competitive Benchmarking
    • 11.1.1. Competitive Dashboard
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Roche Diagnostics
    • 11.2.2. Siemens Healthineers
    • 11.2.3. Fujirebio
    • 11.2.4. Quanterix Corporation
    • 11.2.5. Revvity, Inc.
    • 11.2.6. Abbott Laboratories
    • 11.2.7. Bio-Rad Laboratories, Inc.
    • 11.2.8. Thermo Fisher Scientific Inc.
    • 11.2.9. Sysmex Corporation
    • 11.2.10. Becton, Dickinson and Company (BD)
    • 11.2.11. Agilent Technologies, Inc.
    • 11.2.12. Bio-Techne Corporation
    • 11.2.13. QIAGEN
    • 11.2.14. Diasorin S.p.A.
    • 11.2.15. Beckman Coulter, Inc. (Danaher)
    • 11.2.16. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us